Krishna Institute of Medical Sciences Limited — Investor Meet, 15-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** KIMS Hospitals reported gross revenue of INR 782 crores for the quarter, marking a 19.4% year-over-year increase and a 12.9% quarter-over-quarter rise. EBITDA stood at INR 223 crores, reflecting 23.8% growth year-over-year and 21.2% quarter-over-quarter. The EBITDA margin improved to 28.5%, up from 27.5% a year earlier and 26.6% sequentially. Profit After Tax (PAT) reached INR 120 crores, an increase from INR 101 crores in the previous year and INR 95 crores in the prior quarter.

2. **Future Outlook and Growth Drivers:** Management highlighted ambitions for significant expansion in Kerala, targeting 3,000 new beds over the next 5 to 6 years, primarily through an asset-light business model. The company aims to enhance healthcare accessibility in Tier 2 and Tier 3 towns, capitalizing on local expertise and operational efficiencies.

3. **Order Book and Operational Updates:** KIMS is progressing with the acquisition of hospitals, including Queen's NRI in Vizag and Sreechand Hospital in Kannur, along with operational initiatives in Andhra Pradesh. The addition of a 350-bed hospital in Thrissur dedicated to transplant services is planned.

4. **Analyst Q&A Insights (Detailed):**

- **Revenue and Profitability:** Analysts inquired about the revenue consistency amidst decreasing bed occupancy in Telangana. Management attributed revenue growth to favorable case mix changes rather than structural shifts.

- **Market Position and Competitive Landscape:** Competitive pressures in Kerala and established local players were acknowledged. However, management is optimistic due to strong local talent and the market's maturity.

- **Operational Challenges or Risks:** Concerns regarding debt management and operational costs amidst expanding new units were discussed. Management is focused on maintaining a debt-to-EBITDA ratio of 2, balancing new investments with existing operations.

- **Capex and Capital Allocation:** Analysts discussed the ongoing capital initiatives and the expected capex for further expansions. Management confirmed existing plans for asset-light investments to limit financial burdens.

- **Strategic Priorities and Long-Term Vision:** The focus remains on sustainable growth through careful exploration of asset-light models while addressing regional healthcare gaps.

5. **Market or Regulatory Updates:** No significant regulatory changes were reported during the call that might impact KIMS's strategic direction.

6. **Strategic Focus Areas:** KIMS is centered on innovation in healthcare delivery and expanding its footprint in underserved regions, with strong regional management teams in the newly targeted areas.

7. **Investor Insight:** KIMS Hospitals is positioned favorably for future growth, supported by increasing revenue, expanding operational capacity, and strategic initiatives aimed at overcoming regional challenges. Given the positive financial performance and growth plans, a 'buy' position could be considered for those seeking exposure in the healthcare sector.